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Ossifying fibromyxoid tumor (OFMT) is a rare mesenchymal neoplasm that arises in subcutaneous tissue, with that
in the oral cavity extremely rare. We present a case of malignant OFMT in the tongue. A 26-year-old male noticed
a painless mass in the tongue, which was extracted at a general hospital. Four years later, the tumor recurred and
was resected at our department. Histologically, the recurrent tumor was composed of the closely packed cells
positive for vimentin and S-100 proliferating in a nodular fashion. It showed high cellularity and mitotic activity. In
the primary tumor, some tumor cells were arranged in a diffuse or cord-like manner within an abundant
fibromyxoid matrix, along with a small amount of metaplastic ossification, corresponding with the histopathological
characteristic of OFMT. Accordingly, a diagnosis of malignant OFMT arising in typical OFMT was established. This is
the first reported case of malignant OFMT in the tongue. Long-term follow-up is needed for confirmation of
prognosis and biological behavior.
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Ossifying fibromyxoid tumor (OFMT) is an uncommon
soft tissue neoplasm of uncertain origin, that is com-
posed of relatively uniform round to ovoid cells often
arranged in a corded or trabecular pattern and embed-
ded in a fibromyxoid matrix [1-3]. In addition, a band
of dense collagen with spicules of metaplastic bone is
commonly encountered at the tumor periphery [1,2].
OFMT mostly arises in subcutaneous tissue or skeletal
muscle of the extremities, while it has been reported at
other sites, such as the trunk, head and neck, mediasti-
num and retroperitoneum at low frequency [1,2,4-6].
However, this tumor located in the oral cavity is ex-
tremely rare [2-4,7-9], with no cases of OFMT arising
in the tongue previously reported.
OFMTs are presented as a slow growing painless,
well-defined mass, and generally regarded as benign.
Although most reported cases were cured by local exci-
sion, local recurrence rates ranging from 20% to 27%* Correspondence: otkouji@hiroshima-u.ac.jp
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reproduction in any medium, provided the orhave been reported. In recent years, it was emphasized
that a subset of OFMTs with conventional morphology
displays atypical cytoarchitectural features, such as high
cellularity or elevated mitotic activity and shows corres-
pondingly more aggressive clinical behavior, which is
called as atypical or malignant OFMTs [10,11]. We
present a case of malignant OFMT arising in primary
typical OFMT of the tongue.Case report
A 26-year-old male was referred to an otolaryngology at
a general hospital in August 2003, because he became
aware of a painless mass in the dorsal tongue before two
weeks ago. The mass was a hard, smooth and 7 mm
diameter, and was resected with narrow safety margin as
diagnosis of a benign mesenchymal tumor. The histo-
logical diagnosis was chondromyxoid tumor, which is
unusual, but that was not finally confirmed. After 4 years,
he noticed a painless, mass gradually increasing in the
same part, and consulted our oral and maxillofacial sur-
gery clinic in January 2007.
The patient was healthy, with no family history of
similar symptoms. The mobile pedunclated mass located
at the center of the dorsum of tongue. The mass aboutd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Findings of the mass in the tongue. A: Progressive swelling mass was founded at the tongue. B: Ultrasonographic findings showing
a soft tissue mass. C: The cut section surface of the tumor was gray- white, solid, and firm in consistency.
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reddish and lobulated surface (Figure 1A). Ultrasono-
graphic findings revealed a soft tissue mass in the
tongue, which was 20 × 18 × 10 mm in size (Figure 1B).
An incisional biopsy was performed based on the initial
clinical diagnosis of soft tissue tumor of the tongue,
and histological findings suggested a benign mesenchy-
mal tumor as a possible diagnosis.
Under general anesthesia, the tumor was extirpated
with a safety margin of about 3 mm. Macroscopically,
the tumor was solid and lobular with a grayish white
cut surface, and measured 20 mm at the greatest diam-
eter (Figure 1C). Histologically, the tumor was located
in subepithelial connective tissue and proliferated in a
multinodular fashion (Figure 2A). The mass was rela-
tively well circumscribed but not encapsulated. It was
composed of solid and lobular proliferation of uniform
short spindle or ovoid cells with vesicular nuclei and
indistinct small amounts of eosinophilic or vacuolated
cytoplasm (Figure 2B). In most areas, the tumor cells
were closely packed and showed high cellularity. In
some small areas, they were arranged in a diffuse hap-
hazard or sheet-like fashion with an alcian-blue positive
myxoid or collagenous stroma (Figure 2C).
A variety of lesions with fibromyxoid matrix was consid-
ered as differential diagnosis including myoepithelioma/
myoepithelial carcinoma, ectomesenchymal chondromyxoidtumor of the anterior tongue, epithelioid nerve sheath
tumors and epithelioid smooth muscle tumor. For the
establishment of the diagnosis, immunohistochemical
analysis was performed using various antibodies (Table 1).
The tumor cells expressed vimentin (Figure 3A) and some
of them were also positive for S-100 protein (Figure 3B).
Other markers were not expressed. In spite of scant cellu-
lar and nuclear polymorphism, the mitotic activity was
relatively high, i.e., 2 mitotic figures per 10 high-power
fields (HPFs) with areas showing more than 3 mitoses
in 1 HPF (Figure 3C), and the Ki-67 labeling index was
about 7% (Figure 3D). Detailed analyses were per-
formed, but it was still difficult to further classify this
tumor due to the unusual morphological and immuno-
histochemical features.
We made a tentative diagnosis of mesenchymal tumor
with low-grade malignancy. Since a final diagnosis could
not be established, histological specimens of the primary
tumor were obtained from the pathological department
of the hospital where the patient underwent the initial
treatment. Although the histological appearance was
essentially identical to that of the present extracted
tumor, small amounts of metaplastic ossification and
osteoid was found in the primary tumor (Figure 4A). In
addition, the tumor cells were arranged in a diffuse or
cord-like manner with abundant fibromyxoid matri-
ces (Figure 4B) in some areas. These features and
Figure 2 Histopathological features of the recurrent tumor. A: Multinodular growth pattern without encapsulationis shown. (20x,
Hematoxilin-Eosin staining) B: The tumor was composed of solid proliferating uniform short spindle or ovoid cells with vesicular nuclei, and a
small amount of cytoplasm (100x, Hematoxilin-Eosin staining). C: The tumors cells were separated by alcian blue positive mucoid material in small
areas. (200x, Alcian blue staining).
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of typical OFMT. The recurrent tumor, however,
showed higher cellularity without intervening matrix
and high mitotic activity of more than 2 mitotic fig-
ures/10HPFs, which deviate form the histopathologic
features of typical OFMT and are histologic parameters
suggestive for increased risk of local recurrence and
metastasis. As a result, the final diagnosis of malignant
OFMT arising in typical OFMT was established, al-
though high nuclear grade (defined as irregular nuclear
contours, coarse chromatin, and macronucleoli) was
not observed.Table 1 Primary antibodies used in the analysis of OFMT
Antigen Antibody clone(s) Source of antibody
Vimentin V9 Dako Cytomation, Carpinteria, CA
S100 protein polyclonal Dako Cytomation
GFAP polyclonal Dako Cytomation
Cytokeratins AE1/AE3 Invitrogen, Carlsbad, CA
Cytokeratins CAM5.2 Becton Dickinson, Frankin Lakes, NJ
α-SMA 1A4 Dako Cytomation
Calponin CALP Dako Cytomation
Desmin D33 Dako Cytomation
CD68 KP1 Dako Cytomation
CD34 NU-4A1 Nichirei Biosciences Inc, Tokyo, Japan
P63 4A4 Dako Cytomation
Ki-67 MIB-1 Dako CytomationDiscussion
OFMT is a rare mesenchymal neoplasm initially reported
by Enzinger et al. in 1989, in which, approximately 70% of
the examined cases showed the subcutaneous tissue
involvement in the lower or upper limbs, whereas OFMT
in the head and neck region only accounted for about 13%
of those cases [1]. Involvement in the oral cavity is ex-
tremely rare, with only 7 cases have reported in the soft
palate, buccal mucosa, vestibule, lip, and gingiva (Table 2)
[3,4,7-9]. There are no known previous cases of this tumor
arising in the tongue or malignant OFMT in the oral
cavity.
Clinically, OFMT is usually presented as a slow grow-
ing painless mass. It is most common in the fifth to
seventh decades of life, with male predominance [1,2].
The masses are usually less than 10 cm in diameter
[1,2]. However, Harris et al. reported 9 cases of giant
OFMTs, which had diameters greater than 10 cm [12].
Most of OFMT occurring in oral cavity range in the size
from 60 mm to 10 mm (Table 2), which was also seen in
the present case [2].
Microscopically, OFMTs are composed of uniform
round, ovoid or spindle-shaped cells arranged in nests
and cords with fibromyxoid stroma partially surrounded
by shell of mature bone. Immunohistochemical findings
have revealed that 74% of these tumor are positive for
vimentin and 94% positive for S-100 protein [1,2], fea-
tures consistent with neural crest lineage or cartilaginous
differentiation. The primary tumor in the present case
showed the characteristics of OFMT. The mitotic activ-
ity and nuclear grade were low, although the areas
Figure 3 Immunohistochemical characteristics and proliferative activity of the recurrent tumor. A: Most tumor cells displayed
immunoreactivity for vimentin (40x, Immunohistochemical staining). B: S-100 protein was also expressed in some tumor cells (40x, Immunohistochemical
staining). C: Mitotic figures were easily found (400x, Hematoxilin-Eosin staining). D: Ki-67 positive cells were frequently observed (100x,
Immunohistochemical staining).
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tumor maintained the morphological features of OFMT,
but was composed of closely packed cells with higher
cellularity and mitotic activity in spite of inconspicuous
cell atypia and lacked bone or osteoid formation. Clini-
copathologic study of 70 cases of OFMT by Folpe indi-
cated that the tumors having 1) high nuclear grade or 2)
high cellularity and mitotic activity >2 mitotic figures/
50HPF have a substantial risk of metastasis [10]. The
histological features of the recurrent tumor are consist-
ent with those of malignant OFMT. After revealing the
features of the primary tumor, the recurrent tumor was
finally diagnosed as malignant OFMT arising in typicalFigure 4 Histopathological features of the primary tumor. A: Small am
the primary tumor (40x, Hematoxilin-Eosin staining). B: Cords of tumor cell
Hematoxilin -Eosin staining).OFMT. In 15 cases of malignant OFMTs reported by
Graham et al., malignant foci could be identified in
subsequent local recurrences of initially typical OFMTs
[13]. The percentage of the cases with bone formation
in malignant OFMT is low (47%) than that in typical
one (60%).
Awareness of OFMT occurring in the oral cavity is
important to avoid confusion with other tumors with a
fibromyxoid matrix. Differential diagnosis of OFMT in
the oral cavity includes myoepithelioma and ectome-
senchymal chondromyxoid tumor (ECT) of the anterior
tongue. The absence of epithelial and myoepithe-
lial markers excludes myoepithelioma as a diagnosticounts of metaplastic ossification and osteoid formation were found in
s were seen suspended within a fibromyxoid matrix (100x,
Table 2 Reported cases of ossifying fibromyxoid tumor in the oral cavity
Case Age Gender Location Size
(cm)





1 N / D N / D Lower lip N / D N / D N / D N / D N / D N /D N / D [2]
2 14 F Between buccal and
gingival mucosa
3.5 Nodular swelling Less than 2/
10 HPFs
- + N /D N / D [3]
3 67 F Mandible vestibule 1 N / D N / D N / D N / D No 3 yrs [4]
4 37 M Soft palate 4.5 N / D N / D N / D N / D No 1.5 yrs [4]
5 41 M Inner cheek 1.5 N / D 0-1 / 10
HPFs
- N / D No N / D [7]
6 39 M Lip 1.5 N / D 0-11 / 10
HPFs
- N / D No N / D [7]
7 21 F Mandibular gingiva 6 Reddish, lobulated
surface
No mitosis - + No 7 mos [8]




- + yes 4 yrs Present
case
M = male, F = female, N/D = detail not provided, yr(s) = years, mo(s) = month(s), HPFs = high power fields.
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that usually arises in the submucosa of the anterior
dorsum of the tongue. Its histogenesis is unclear,
though it is possibly derived from undifferentiated ec-
tomesenchymal progenitor cells that have migrated
form the neural crest. ECT is composed of round, fusi-
form or polygonal cells with a chondromyxoid matrix,
resembling the features of OFMT. However, the tumor
cells of ECT strongly express GFAP, which is different
from the immuno-profile of OFMT. Furthermore, ECT
lacks bone and osteoid formation. The line of differen-
tiation of OFMT remains controversial. Graham et al.
described that expression of neuron-related markers, in
addition to Schwann cell and cartilage-associated mar-
kers, suggests a “scrambled” phenotype in this tumor.
Genetic studies on OFMT are limited. Graham et al.
suggested that OFMT develops primarily through inacti-
vation of the SMARCB1 (also known as INI-1 or SNF5)
gene in chromosome band 22q11 [13]. Furthermore,
gene expression profiling showed typical and malignant
OFMTs to cluster together. Whereas, Gebre-Medhin
et al. reported that the pathogenetic basis of OFMT fre-
quently involves rearrangement of the PHF1 gene,
suggesting that epigenetic deregulation of PRC2 target
genes is crucial for tumor development regardless of
types such typical, atypical and malignant [14]. There-
fore, cytogenetic assay and FISH tests for reaarangment
of these genes may be useful diagonstic tools in
ambiguaous cases of OFMT.
In the series of Graham et al., all patients with typical
and atypical OFMT were alive without local recurrence
and metastasis, but adverse events were seen in 33% of
patients with malignant OFMT, including 2 patients
with local recurrences, 3 patients with distant metasta-
ses, and 3 deaths from disease [13]. Therefore, carefulfollow-up examinations will be mandatory for the
present patients.
Conclusion
We present the first reported case of malignant OFMT
with recurrence arising in typical OFMT of the tongue.
In the primary tumor, some tumor cells were arranged
in a diffuse or cord-like manner within an abundant
fibromyxoid matrix, along with a small amount of meta-
plastic ossification, corresponding with the histopatho-
logical characteristic of OFMT, whereas the recurrent
tumor was regarded as a malignant OFMT because of
increased cellularity and mitotic activity. Therefore,
long-term follow-up is needed for confirmation of the
biological behavior.
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